Literature DB >> 2655712

Analysis of cancer-associated colonic mucin by ion-exchange chromatography: evidence for a mucin species of lower molecular charge and weight in cancer.

C Shimamoto1, G D Deshmukh, W L Rigot, C R Boland.   

Abstract

Cancer-associated mucins in the colon are antigenically distinct and glycosylated differently from their normal counterparts. Mucin-rich glycoconjugate preparations were made from nine non-neoplastic colons, seven colon cancers, and two different xenografts from mucin-producing human colon cancer cell lines, and radiolabeled with 3H. The preparation was applied to a DEAE-cellulose ion-exchange column, and eluted with a discontinuous ascending NaCl gradient resulting in seven discrete fractions or 'species'. Over half of the 3H-labeled glycoconjugates from specimens of non-neoplastic colonic epithelium eluted in fraction V (eluted with 0.25 NaCl). Significantly less of the 3H-labeled glycoconjugates from specimens of colon cancer eluted in fraction V (34%, P less than 0.0005), and there were significant increases in glycoconjugates eluted in fractions IV (P less than 0.008), III (P less than 0.0005), and II (P less than 0.028). Additional samples were prepared without the radiolabeling procedures, chromatographed on a DEAE-cellulose ion-exchange column, and analyzed for monosaccharide content. Each of the fractions contained the monosaccharides expected in mucin-type glycoproteins, but only sialic acid was differentially expressed in the seven fractions or 'species', occurring principally in the more charged species. However, differences in sialic acid content were not sufficient to explain the differences in retention on the ion-exchange column, nor were differences in O-acetylation of the mucins. Mucin-type glycoconjugates from colon cancers are relatively less charged than those from the normal colon, and elute at lower ionic strengths. Of interest, cancer-associated mucins appear to be of lower molecular weight than their normal counterparts. Additional studies of oligosaccharide and apomucin structure will be required to explain the molecular basis of these differences in charge.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2655712     DOI: 10.1016/0304-4165(89)90118-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Reduction of sialic acid O-acetylation in human colonic mucins in the adenoma-carcinoma sequence.

Authors:  A P Corfield; N Myerscough; B F Warren; P Durdey; C Paraskeva; R Schauer
Journal:  Glycoconj J       Date:  1999-06       Impact factor: 2.916

2.  76th General Meeting of the Japanese Society of Gastroenterology. Tokyo, Japan, March 29-31, 1990. Abstracts.

Authors: 
Journal:  Gastroenterol Jpn       Date:  1992-02

3.  Clement Richard Boland, Jr., MD: a conversation with the editor. Interview by William Clifford Roberts.

Authors:  Clement Richard Boland
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-10

Review 4.  Mucin glycoproteins in neoplasia.

Authors:  Y S Kim; J Gum; I Brockhausen
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

5.  Ion exchange chromatography of purified colonic mucus glycoproteins in inflammatory bowel disease: absence of a selective subclass defect.

Authors:  A Raouf; N Parker; D Iddon; S Ryder; B Langdon-Brown; J D Milton; R Walker; J M Rhodes
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

6.  Diagnosis of Malignant Potential in Mucinous Peritoneal Neoplasms by Characterization of Mucin Carbohydrate Structure.

Authors:  L August Clark; Alexia Ghazi; Kristin Gaffney; Rodrigo Soto; Atin Agarwal; Susanne Carmack; C Richard Boland
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-03-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.